Pinnacle Wealth Advisors’s Pfizer PFE Stock Holding History

Pinnacle Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$12.7M	Buy	+323,582	New	+$12.6M	0.51%	65

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pinnacle Wealth Advisors's PFE Position: Q2 2021 in Review

Pinnacle Wealth Advisors opened a new position in Pfizer (PFE) in Q2 2021: 323,582 shares worth $12.7M. The stake represents 0.51% of the portfolio and ranks #65 among its holdings.

2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Pinnacle Wealth Advisors held 323,582 shares of Pfizer worth $12.7M as of Q2 2021.
Pfizer was a new Pinnacle Wealth Advisors position in Q2 2021.
Pfizer made up 0.51% of Pinnacle Wealth Advisors's portfolio in Q2 2021, its #65 holding.
2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Pinnacle Wealth Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.